Serina Therapeutics, Inc. Stock-Based Compensation
Serina Therapeutics, Inc. (SER) reported Stock-Based Compensation of $956.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-05-08
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $956.00K, a 1703.77% increase year-over-year.
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $988.00K.
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $1.10M.
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-06-30 was $458.00K, a 1891.30% increase year-over-year.
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $2.60M, a 10280.00% increase from fiscal 2023.
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $25.00K, a 96.71% decline from fiscal 2022.
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $760.00K, a 23.92% decline from fiscal 2021.
- Serina Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $999.00K, a 9.90% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $956.00K 10-Q · filed 2025-05-08 | $1.94M derived: sum of 2 quarters · filed 2025-05-08 | $3.04M derived: sum of 3 quarters · filed 2025-05-08 | $3.50M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2024-12-31 | $988.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $2.08M derived: sum of 2 quarters · filed 2025-03-24 | $2.54M derived: sum of 3 quarters · filed 2025-03-24 | $2.60M 10-K · filed 2025-03-24 | ||||
| 2024-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.55M derived: sum of 2 quarters · filed 2024-11-12 | $1.61M 10-Q · filed 2024-11-12 | $1.61M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2024-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $511.00K 10-Q · filed 2024-08-09 | $511.00K derived: sum of 3 quarters · filed 2025-05-08 | $511.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2024-03-31 | $53.00K 10-Q · filed 2025-05-08 | $53.00K derived: sum of 2 quarters · filed 2025-05-08 | $53.00K derived: sum of 3 quarters · filed 2025-05-08 | $76.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $23.00K derived: sum of 3 quarters · filed 2025-03-24 | $25.00K 10-K · filed 2025-03-24 | $648.00K 10-K · filed 2024-03-22 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $23.00K derived: sum of 2 quarters · filed 2024-11-12 | $25.00K 10-Q · filed 2024-11-12 | $145.00K 10-Q · filed 2023-11-14 | $139.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $25.00K 10-Q · filed 2024-08-09 | $105.00K 10-Q · filed 2023-08-14 | $139.00K derived: sum of 3 quarters · filed 2024-08-09 | $348.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-14 | $70.00K 10-Q · filed 2023-05-12 | $116.00K derived: sum of 2 quarters · filed 2024-05-14 | $325.00K derived: sum of 3 quarters · filed 2024-05-14 | $523.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $323.00K derived: sum of 2 quarters · filed 2024-03-22 | $521.00K derived: sum of 3 quarters · filed 2024-03-22 | $760.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $407.00K derived: sum of 2 quarters · filed 2023-11-14 | $646.00K 10-Q · filed 2023-11-14 | $909.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $437.00K 10-Q · filed 2023-08-14 | $700.00K derived: sum of 3 quarters · filed 2023-08-14 | $972.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $239.00K 10-Q · filed 2023-05-12 | $502.00K derived: sum of 2 quarters · filed 2023-05-12 | $774.00K derived: sum of 3 quarters · filed 2023-05-12 | $1.06M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $535.00K derived: sum of 2 quarters · filed 2023-03-31 | $821.00K derived: sum of 3 quarters · filed 2023-03-31 | $999.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $272.00K 10-Q · filed 2021-11-12 | $558.00K derived: sum of 2 quarters · filed 2021-11-12 | $736.00K 10-Q · filed 2022-11-10 | $913.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2021-06-30 | $286.00K 10-Q · filed 2021-08-13 | $464.00K 10-Q · filed 2022-08-12 | $641.00K derived: sum of 3 quarters · filed 2022-05-13 | $868.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2021-03-31 | $178.00K 10-Q · filed 2022-05-13 | $355.00K derived: sum of 2 quarters · filed 2022-05-13 | $582.00K derived: sum of 3 quarters · filed 2022-05-13 | $834.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $404.00K derived: sum of 2 quarters · filed 2022-03-29 | $656.00K derived: sum of 3 quarters · filed 2022-03-29 | $909.00K 10-K · filed 2022-03-29 | $933.00K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $227.00K 10-Q · filed 2021-11-12 | $232.00K 10-Q · filed 2020-11-16 | $479.00K derived: sum of 2 quarters · filed 2021-11-12 | $732.00K 10-Q · filed 2021-11-12 | $751.00K 10-Q · filed 2020-11-16 | $1.15M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $252.00K 10-Q · filed 2021-08-13 | $259.00K 10-Q · filed 2020-08-14 | $505.00K 10-Q · filed 2021-08-13 | $519.00K 10-Q · filed 2020-08-14 | $924.00K derived: sum of 3 quarters · filed 2021-08-13 | $1.42M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $252.00K 10-Q · filed 2021-05-17 | $260.00K 10-Q · filed 2020-05-14 | $672.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.16M derived: sum of 3 quarters · filed 2021-05-17 | $1.68M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $911.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.43M derived: sum of 3 quarters · filed 2021-03-31 | $1.91M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $491.00K 10-Q · filed 2020-11-16 | $1.01M derived: sum of 2 quarters · filed 2020-11-16 | $1.49M 10-Q · filed 2020-11-16 | $2.28M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $515.00K 10-Q · filed 2020-08-14 | $996.00K 10-Q · filed 2020-08-14 | $1.79M derived: sum of 3 quarters · filed 2020-08-14 | $2.00M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $481.00K 10-Q · filed 2020-05-14 | $1.28M derived: sum of 2 quarters · filed 2020-05-14 | $1.49M derived: sum of 3 quarters · filed 2020-05-14 | $1.72M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $797.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $1.01M derived: sum of 2 quarters · filed 2020-03-31 | $1.24M derived: sum of 3 quarters · filed 2020-03-31 | $1.28M 10-K/A · filed 2020-03-31 | ||||
| 2018-09-30 | $210.00K 10-Q · filed 2019-11-14 | $441.00K derived: sum of 2 quarters · filed 2019-11-14 | $488.00K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $231.00K 10-Q · filed 2019-08-14 | $312.00K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $145.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $114.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |